Ampac announces a new low extractable barrier lamination, PRO FlexiPURETM, which enhances the existing family of successful barrier drug and medical device overwrap laminations for the pharmaceutical and medical device markets.

Ampac, a division of ProAmpac, announces a new low extractable barrier lamination, PRO FlexiPURETM, which enhances the existing family of successful barrier drug and medical device overwrap laminations for the pharmaceutical and medical device markets.

As analytical equipment has improved, detection limits of trace contaminants have lowered. In..

View more at http://www.1888pressrelease.com/ampac-announces-low-extractable-barrier-lamination-pro-fle-pr-591280.html